Risultati della ricerca - Hacer Coşkun

Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines di Hasumati Rahalkar, Hasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek

Connect to this object online.

The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore di Emel Mashaki Ceyhan, Emel Mashaki Ceyhan, Hakki Gürsöz, Ali Alkan, Hacer Coşkun, Oğuzhan Koyuncu, Stuart Walker, Stuart Walker

Connect to this object online.

Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines di Oguzhan Koyuncu, Oguzhan Koyuncu, Hakki Gursoz, Ali Alkan, Hacer Coskun Cetintas, Tuncay Pasaoglu, Emel Mashaki Ceyhan, Emel Mashaki Ceyhan, Stuart Walker, Stuart Walker

Connect to this object online.